[go: up one dir, main page]

LV10839A - Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens - Google Patents

Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens

Info

Publication number
LV10839A
LV10839A LV931238A LV931238A LV10839A LV 10839 A LV10839 A LV 10839A LV 931238 A LV931238 A LV 931238A LV 931238 A LV931238 A LV 931238A LV 10839 A LV10839 A LV 10839A
Authority
LV
Latvia
Prior art keywords
treatment
prophylaxis
lipid
metabolic disorders
healing agent
Prior art date
Application number
LV931238A
Other languages
English (en)
Other versions
LV10839B (en
Inventor
Hans-Ludwig Schaefer
Werner Schneider
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of LV10839A publication Critical patent/LV10839A/lv
Publication of LV10839B publication Critical patent/LV10839B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
LVP-93-1238A 1990-04-06 1993-11-17 Remedy for prophylactics and treatment of lipoid and cholesterol metabolism upset, method for prophylactics and treatment thereof LV10839B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4011285A DE4011285A1 (de) 1990-04-06 1990-04-06 Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose
PCT/EP1991/000654 WO1991015214A1 (de) 1990-04-06 1991-04-06 Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose

Publications (2)

Publication Number Publication Date
LV10839A true LV10839A (lv) 1995-10-20
LV10839B LV10839B (en) 1996-04-20

Family

ID=6403968

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1238A LV10839B (en) 1990-04-06 1993-11-17 Remedy for prophylactics and treatment of lipoid and cholesterol metabolism upset, method for prophylactics and treatment thereof

Country Status (17)

Country Link
US (1) US5434141A (lv)
EP (1) EP0476113B1 (lv)
JP (1) JPH05500673A (lv)
KR (1) KR920700656A (lv)
AT (1) ATE135223T1 (lv)
AU (1) AU639097B2 (lv)
CA (1) CA2063588A1 (lv)
DE (2) DE4011285A1 (lv)
DK (1) DK0476113T3 (lv)
ES (1) ES2086538T3 (lv)
GR (1) GR3019866T3 (lv)
HU (1) HU218925B (lv)
LT (1) LT3543B (lv)
LV (1) LV10839B (lv)
RU (1) RU2108788C1 (lv)
UA (1) UA35566C2 (lv)
WO (1) WO1991015214A1 (lv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6084067A (en) * 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
US6824779B1 (en) 1993-07-26 2004-11-30 Dana-Farber Cancer Institute, Inc. Methods for inhibiting the interaction of B7-2 with its natural ligand
JPH0948732A (ja) * 1995-08-04 1997-02-18 Pola Chem Ind Inc 活性酸素消去剤及びそれを含む組成物
JP5020424B2 (ja) * 1996-08-09 2012-09-05 マナテック・インコーポレイテッド 食物補強剤としての植物炭水化物の組成物
US6929807B1 (en) 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US5942500A (en) * 1998-04-27 1999-08-24 Perry; Stephen C. Dietary composition to reduce dietary fats
US6462029B1 (en) * 1999-02-23 2002-10-08 Econugenics Compositions and methods for treating mammals with modified alginates and modified pectins
WO2008011216A2 (en) 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
WO2012138213A1 (en) * 2011-04-08 2012-10-11 N.V. Nutricia Reduction of vascular dysfunction with specific saccharides
EP2755480B1 (en) 2011-09-16 2021-03-31 Galectin Therapeutics Inc. Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease
ES2848538T3 (es) 2012-06-06 2021-08-10 Galectin Therapeutics Inc Composiciones de galacto-ramnogalacturonato para el tratamiento de enfermedades asociadas con elevada óxido nítrico sintasa inducible

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2370961A (en) * 1941-11-15 1945-03-06 Rohm & Haas Preparation of alpha-d-galacturonic acid
DE2036605A1 (de) * 1970-07-23 1972-05-31 Mylaeus, Armin, 5970 Plettenberg Diätbrot und Verfahren zu seiner Herstellung
DE2521765B2 (de) * 1975-05-16 1979-01-18 Valentin Dr.Med. Koehler Verwendung von D-Glucuronsäure, dessen γ -Lacton, Galacturonsäure oder Mannuronsäure
US4122179A (en) * 1976-06-03 1978-10-24 Enrico Corvi Mora Acid addition salts of vincamine and apovincamine
JPS54119038A (en) * 1978-03-07 1979-09-14 Takeda Chemical Industries Ltd Digestion difficult polysaccaride containing food
FR2449452A1 (fr) * 1978-11-15 1980-09-19 Krauter Henri Nouveau medicament utile notamment comme diuretique et detoxicant, derive de l'acide galacturonique
JPS59206045A (ja) * 1983-05-11 1984-11-21 Asahi Chem Ind Co Ltd 低比重リポ蛋白質吸着材
DD271415A3 (de) * 1983-07-05 1989-09-06 Akad Wissenschaften Ddr Verfahren zur herstellung eines pektindiaetetikums
US4617276A (en) * 1985-01-23 1986-10-14 Agway Inc. Novel method for quantitating structural and non-structural carbohydrates in feedstuffs
US4615891A (en) * 1985-01-23 1986-10-07 Agway Inc. Method of formulating dairy cow rations based on carbohydrate regulation
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
DK81690D0 (da) * 1990-03-30 1990-03-30 Grindsted Prod As Pektinprodukt og fremgangsmaade til fremstilling deraf

Also Published As

Publication number Publication date
KR920700656A (ko) 1992-08-10
EP0476113B1 (de) 1996-03-13
UA35566C2 (uk) 2001-04-16
JPH05500673A (ja) 1993-02-12
AU7664991A (en) 1991-10-30
WO1991015214A1 (de) 1991-10-17
LT3543B (en) 1995-11-27
HUT61199A (en) 1992-12-28
CA2063588A1 (en) 1991-10-07
RU2108788C1 (ru) 1998-04-20
EP0476113A1 (de) 1992-03-25
ES2086538T3 (es) 1996-07-01
HU218925B (hu) 2000-12-28
DE4011285A1 (de) 1991-10-10
AU639097B2 (en) 1993-07-15
DE59107536D1 (de) 1996-04-18
LTIP1534A (en) 1995-06-26
DK0476113T3 (da) 1996-07-15
HU913814D0 (en) 1992-04-28
GR3019866T3 (en) 1996-08-31
LV10839B (en) 1996-04-20
US5434141A (en) 1995-07-18
ATE135223T1 (de) 1996-03-15

Similar Documents

Publication Publication Date Title
FI970101A0 (fi) Uusi farmaseuttinen valmiste kivun hallintaan
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
AU5157096A (en) Fabric article with extension indicator
SE9500422D0 (sv) New oral pharmaceutical dosage forms
KR900009079A (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
AU7316591A (en) Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
NO2012003I1 (no) 4-aminopyridin eller et derivat derav
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
TW261532B (lv)
NO179245C (no) Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet
PT783495E (pt) Derivados de quinoxalina uteis em terapia
NO874241D0 (no) Terapeutisk aktive salter.
KR100194995B1 (ko) 관상동맥성 심장질환,동맥경화증 및(또는)지방단백질 대사 이상 치료용 약제
EP0286802A3 (en) Use of ofloxacin in treating or preventing locally periodontal disease
GR3019819T3 (en) Use of wild garlic for the therapy or prevention of blood circulation disturbances.
SE9403861D0 (sv) Novel medicinal use
FR2657005B1 (fr) Systeme d'enclouage pour le traitement des fractures notamment du type cervico-trochanteriennes et pertrochanteriennes.
ATE246927T1 (de) Cholesterin senkende mercaptoacetylamiddisulfidderivate
JO1917B1 (en) A different method for controlling high levels of bilirubin in the blood in newborns
ATE150645T1 (de) Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen
DK0868181T3 (da) Anvendelse af alfa,alfa-diphenyleddikesyre-4-(N-methyl-piperidyl)-estere som spasmoanalgetikum
YU15301A (sh) PRIMENA R (+)- alfa-(2,3-DIMETOKSIFENIL)-1-[2-(4-FLUOROFENIL) ETIL] -4-PIPERIDINMETANOLA ZA LECENJE POREMEĆAJA SPAVANJA